Integra Lifesciences Holdings Corp
IART- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000917520
No open-market purchases or sales by Integra Lifesciences Holdings Corp insiders were filed in the last 90 days; 212 institutions reported holding it in 13F filings for Q2 2026, worth $1.32B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Integra Lifesciences Holdings Corp as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 223
- +1 vs. Q3 2024
- Shares held
- 69.3M
- −964.2K (−1.4%) vs. Q3 2024
- Total value
- $1.57B
- +$329.7M (+26.5%) vs. Q3 2024
- New holders
- 41
- 78 more added
- Sold out
- 40
- 69 more reduced
3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IART on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 212 | $1.32B |
| Q1 2026 | 202 | $704.7M |
| Q4 2025 | 205 | $919.4M |
| Q3 2025 | 207 | $1.04B |
| Q2 2025 | 209 | $896.9M |
| Q1 2025 | 220 | $1.62B |
| Q4 2024 | 223 | $1.57B |
| Q3 2024 | 225 | $1.24B |
| Q2 2024 | 238 | $2.07B |
| Q1 2024 | 281 | $2.34B |
| Q4 2023 | 284 | $2.92B |
| Q3 2023 | 263 | $2.63B |
| Q2 2023 | 283 | $2.85B |
| Q1 2023 | 280 | $4.18B |
| Q4 2022 | 281 | $4.20B |
| Q3 2022 | 282 | $3.13B |
| Q2 2022 | 285 | $3.95B |
| Q1 2022 | 278 | $4.80B |
| Q4 2021 | 277 | $5.19B |
| Q3 2021 | 262 | $5.27B |
| Q2 2021 | 264 | $5.10B |
| Q1 2021 | 257 | $5.10B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Integra Lifesciences Holdings Corp; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Glenmede Trust Co NA | 721,811 | $16.4M | 0.08% | −5,970−0.8% | Reduced |
| Voloridge Investment Management, LLC | 729,416 | $16.5M | 0.06% | −329,710−31.1% | Reduced |
| D. E. Shaw & Co., Inc. | 733,551 | $16.6M | 0.02% | −289,713−28.3% | Reduced |
| Systematic Financial Management LP | 860,563 | $19.5M | 0.50% | +248,817+40.7% | Added |
| Northern Trust Corp | 892,425 | $20.2M | 0.00% | +80,090+9.9% | Added |
| Neuberger Berman Group LLC | 919,450 | $20.8M | 0.02% | +43,870+5.0% | Added |
| Charles Schwab Investment Management Inc | 1,047,573 | $23.8M | 0.00% | +103,291+10.9% | Added |
| Soleus Capital Management, L.P. | 1,276,000 | $28.9M | 2.19% | +1,276,000 | New |
| Lord, Abbett & Co. LLC | 1,332,031 | $30.2M | 0.10% | +618,773+86.8% | Added |
| Capital Research Global Investors | 1,400,559 | $31.8M | 0.01% | +95,944+7.4% | Added |
| Paradigm Capital Management Inc | 1,431,100 | $32.5M | 1.50% | +901,600+170.3% | Added |
| Geode Capital Management, LLC | 1,576,658 | $35.8M | 0.00% | −247,336−13.6% | Reduced |
| Goldman Sachs Group Inc | 1,624,721 | $36.8M | 0.01% | +318,203+24.4% | Added |
| Invesco Ltd. | 2,066,285 | $46.9M | 0.01% | −4,772−0.2% | Reduced |
| Dimensional Fund Advisors LP | 2,371,725 | $53.8M | 0.01% | −32,124−1.3% | Reduced |
| Wellington Management Group LLP | 2,506,138 | $56.8M | 0.01% | +303,779+13.8% | Added |
| Alliancebernstein L.P. | 2,578,393 | $58.5M | 0.02% | −443,597−14.7% | Reduced |
| Rubric Capital Management LP | 2,618,341 | $59.4M | 1.08% | +2,325,258+793.4% | Added |
| State Street Corp | 2,852,917 | $64.7M | 0.00% | +26,662+0.9% | Added |
| Fuller & Thaler Asset Management, Inc. | 3,932,279 | $89.2M | 0.34% | −35,283−0.9% | Reduced |
| Morgan Stanley | 5,321,243 | $120.7M | 0.01% | +64,887+1.2% | Added |
| Vanguard Group Inc | 7,580,967 | $171.9M | 0.00% | −162,961−2.1% | Reduced |
| BlackRock, Inc. | 11,128,390 | $252.4M | 0.01% | +242,167+2.2% | Added |
| Sachem Head Capital Management LP | 0 | $0 | 0.00% | −2,430,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −614,682−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −338,094−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −234,506−100.0% | Sold out |
| Hussman Strategic Advisors, Inc. | 0 | $0 | 0.00% | −147,000−100.0% | Sold out |
| Penn Capital Management Co Inc | 0 | $0 | 0.00% | −118,888−100.0% | Sold out |
| GMT Capital Corp | 0 | $0 | 0.00% | −2,000,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −67,230−100.0% | Sold out |
| Easterly Investment Partners LLC | 0 | $0 | 0.00% | −61,454−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −52,850−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −42,580−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −41,442−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −40,413−100.0% | Sold out |
| Versor Investments LP | 0 | $0 | 0.00% | −33,700−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −32,764−100.0% | Sold out |
| Bridgewater Associates, LP | 0 | $0 | 0.00% | −29,533−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −28,211−100.0% | Sold out |
| Petrus Trust Company, LTA | 0 | $0 | 0.00% | −24,304−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −24,004−100.0% | Sold out |
| Tandem Capital Management Corp | 0 | $0 | 0.00% | −20,140−100.0% | Sold out |
| Counterpoint Mutual Funds LLC | 0 | $0 | 0.00% | −15,548−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −14,135−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −14,055−100.0% | Sold out |
| Irenic Capital Management LP | 0 | $0 | 0.00% | −11,786−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −11,645−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −10,889−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −10,561−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −1,800−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −873−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −605−100.0% | Sold out |
| Smithfield Trust Co | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Red Tortoise LLC | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| Johnson Financial Group, Inc. | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| Tidemark, LLC | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Mendota Financial Group, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Claris Advisors, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| DiNuzzo Private Wealth, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Raymond James & Associates | – | – | – | – | Not filed |
| Northwest Investment Counselors, LLC | – | – | – | – | Not filed |
| Planning Capital Management Corp | – | – | – | – | Not filed |